Dr. Bartlett
Pittsburgh, PA
Dr. David Bartlett
Chief, Division of Surgical Oncology
5115 Centre Avenue
Pittsburgh, PA 15232
(412) 692-2852
Rice University
University of Texas - 1987
The Hospital of Pennsylvania
Memorial Sloan-Kettering Cancer Center
Professional Highlights
Dr. David Bartlett is board certified in general surgery and specializes in treating peritoneal mesothelioma and other carcinomas that develop in the peritoneal region such as liver and bile duct cancer and abdominal sarcomas. A specific area of interest to Dr. Bartlett is the research and development of new treatment techniques for patients that have developed cancer in the peritoneal cavity. His expertise lies in delivering targeted chemotherapy agents directly to the blood vessels that are associated with a tumor. He has also assisted with developing a technique to deliver chemotherapy directly into the peritoneal cavity in patients that present with localized malignancies in that region.
In addition to being a Professor of Surgery at the University of Pittsburgh School of Medicine, Dr. Bartlett is the vice chairman for surgical oncology at UPMC Cancer Centers and the director of Multidisciplinary Disease Research and Clinical Programs for the University of Pittsburgh Cancer Institute.
Educational Background and Professional Appointments
Upon receiving his undergraduate degree from Rice University in Houston, Texas, Dr. Bartlett attended the University of Texas where he earned his medical degree. He completed his residency work at The Hospital of Pennsylvania in Philadelphia and completed a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center.
The Society of Laparoendoscopic Surgeons, American Society of Peritoneal Surface Malignancies, American Medical Association and the American Society of Gene Therapy are just a few of the many professional organizations that Dr. Bartlett belongs to.
Publications and Research by David Bartlett, M.D.
Dr. Bartlett has conducted research at the National Cancer Institute to develop new surgical techniques that resulted in improved survival rates for patients with cancer of the abdomen and liver. In addition to his work in developing techniques to deliver targeted chemotherapy to tumor sites, he is also now investigating techniques to deliver gene therapy directly to tumors. He is the author of many articles that have appeared in peer reviewed journals on topics such as targeted regional treatment and gene therapies and he has also written several medical textbook chapters on the topics of surgical oncology and cancer therapy.
Source
UPMC Cancer Centers Physician Profile
